COVID-19 is most transmissible 2 days before and 3 days after symptoms appear

Translate to Spanish or other 102 languages!

A new study co-led by a Boston University School of Public Health (BUSPH) researcher has found that individuals infected with the virus are most contagious two days before, and three days after, they develop symptoms. Image for illustration purposes

Mega Doctor News

- Advertisement -

By Boston University School of Medicine

Newswise — Each wave of the pandemic has underscored just how gravely contagious COVID-19 is, but there is less clarity among experts on exactly when—and to what extent—infected individuals are most likely to spread the virus.

Now, a new study co-led by a Boston University School of Public Health (BUSPH) researcher has found that individuals infected with the virus are most contagious two days before, and three days after, they develop symptoms.

- Advertisement -

Published in the journal JAMA Internal Medicine, the study also found that infected individuals were more likely to be asymptomatic if they contracted the virus from a primary case (the first infected person in an outbreak) who was also asymptomatic.

“In previous studies, viral load has been used as an indirect measure of transmission,” says Dr. Leonardo Martinez, assistant professor of epidemiology at BUSPH, and who co-led the study with Dr. Yang Ge, research assistant in the Department of Epidemiology & Biostatistics at the University of Georgia College of Public Health. “We wanted to see if results from these past studies, which show that that COVID cases are most transmissible a few days before and after symptom onset, could be confirmed by looking at secondary cases among close contacts.”

Martinez and colleagues conducted contact tracing and studied COVID-19 transmission among approximately 9,000 close contacts of primary cases in the Zhejiang province of China from January 2020 to August 2020. “Close” contacts included household contacts (defined as individuals who lived in the same household or who dined together), co-workers, people in hospital settings, and riders in shared vehicles. The researchers monitored infected individuals for at least 90 days after their initial positive COVID test results to distinguish between asymptomatic and pre-symptomatic cases.

Of the individuals identified as primary cases, 89 percent developed mild or moderate symptoms, and only 11 percent were asymptomatic—and no one developed severe symptoms. Household members of primary cases, as well as people who were exposed to primary cases multiple times or for longer durations of time, had higher infection rates than other close contacts. But regardless of these risk factors, close contacts were more likely to contract COVID-19 from the primary infected individual if they were exposed shortly before or after the individual developed noticeable symptoms.

- Advertisement -

“Our results suggest that the timing of exposure relative to primary-case symptoms is important for transmission, and this understanding provides further evidence that rapid testing and quarantine after someone is feeling sick is a critical step to control the epidemic,” Dr. Martinez says.

In comparison to mild and moderate symptomatic individuals, asymptomatic primary individuals were much less likely to transmit COVID to close contacts—but if they did, the contacts were also less likely to experience noticeable symptoms.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Heart Earns National Recognition for Exceptional Stroke Care

Despite significant advances in prevention and treatment, cardiovascular disease remains the leading cause of death in the United States, accounting for nearly three in 10 deaths nationwide and claiming more than 940,000 lives each year, according to the Centers for Disease Control and Prevention (CDC).

STHS McAllen Recognized as National Leader in Stroke Care with 7th Consecutive Gold Plus Award

Stroke is the fifth-leading cause of death in the United States and one of the leading causes of serious long-term disability nationwide, according to the Stroke Awareness Foundation, affecting nearly 800,000 Americans each year.

Medicare’s New $50 GLP-1 Coverage: 7 Essential Facts to Know

For decades, it’s been against the law for Medicare to pay for weight-loss medication, but that changed on July 1, with the launch of a new program called Bridge. It gives some people over 65, or who have Medicare for other reasons, access to some weight management medications if they meet certain weight and health criteria.

STHS Celebrates the Arrival of Two Independence Day Babies on America’s 250th Birthday

As the United States celebrated 250 years of independence, two Rio Grande Valley families welcomed historic milestones of their own.
- Advertisement -